Gan & Lee Pharmaceuticals Co., Ltd.
Records under this name other than the patents Gan & Lee Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 4 of 4 · Back to Gan & Lee Pharmaceuticals Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,339,171 | MDM2 inhibitors Lapsed on the fee record Ended May 24, 2026 · USPTO record | Lapsed on the fee record | Ended May 24, 2026 | USPTO record |
| US 11,091,476 | Protein kinase inhibitors, preparation method and medical use thereof Lapsed on the fee record Ended Aug 17, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 17, 2025 | USPTO record |
| US 10,696,678 | Kinase inhibitor, and preparing method and pharmaceutical use thereof Lapsed on the fee record Ended Jun 30, 2024 · USPTO record | Lapsed on the fee record | Ended Jun 30, 2024 | USPTO record |
| US 9,187,520 | Method for preparing insulin glargine crystal Lapsed on the fee record Ended Nov 17, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 17, 2023 | USPTO record |